efavirenz/emtricitabine/tenofovir disoproxil zentiva
zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir
tenofovir disoproxil axunio 245 mg filmdragerad tablett
tenofovirdisoproxil laurus 245 mg filmdragerad tablett
mycobutin 150mg hard capsules
pfizer healthcare ireland - rifabutin - capsule, hard - 150 milligram(s) - antibiotics; rifabutin
efavirenz/emtricitabine/tenofovirdisoproxil cf 600/200/245 mg, filmomhulde tabletten
viropil tablets film-coated
emcure pharmaceuticals ltd. - dolutegravir (dolutegravir sodium), lamivudine, tenofovir disoproxil fumarate - tablets film-coated - 50mg+ 300mg+ 300mg
emtricitabin/tenofovirdisoproxil beta 200 mg/245 mg filmtabletten